Invasive Ductal Breast Carcinoma Active Not Recruiting Phase 2 Trials for Trastuzumab (DB00072)

Also known as: Invasive Ductal Breast Cancer / Carcinoma, Ductal, Breast / Infiltrating ductular carcinoma / Breast ductal cancer invasive / Breast ductal cancer infiltrating / Infiltrating ductal breast cancer

IndicationStatusPhase
DBCOND0047004 (Invasive Ductal Breast Carcinoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02682693Denosumab as an add-on Neoadjuvant Treatment (GeparX)Treatment